← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 22, 2019Last known activity
Sep 30, 2025
Acquired by Swedish Orphan Biovitrum → Advent International on Dec 15, 2025
Timeline
2010s
- Jun 1, 2017
Arthrosi Therapeutics— Founded
2020s
- Sep 8, 2021
Advent International— Now
- Dec 15, 2025
Swedish Orphan Biovitrum— Acquired By
Drugs by trial phase (3 distinct, 10 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (16)
- NCT07116746Lead sponsorPhase 2Sep 30, 2025
- NCT07116746OfficialPhase 2Sep 30, 2025
- NCT06846515OfficialPhase 3Feb 28, 2025
- NCT06846515Lead sponsorPhase 3Feb 28, 2025
- NCT06439602OfficialPhase 3Jun 26, 2024
- NCT06439602Lead sponsorPhase 3Jun 26, 2024
- NCT05253833Lead sponsorPhase 2Aug 12, 2022
- NCT05253833Study chairPhase 2Aug 12, 2022
- NCT05119686Lead sponsorPhase 2Nov 16, 2021
- NCT05119686Study chairPhase 2Nov 16, 2021
- NCT04646889Study directorPhase 1Dec 31, 2020
- NCT04646889Lead sponsorPhase 1Dec 31, 2020
- NCT04508426Lead sponsorPhase 1Jul 16, 2020
- NCT04155918Lead sponsorPhase 2Dec 31, 2019
- NCT04314986Lead sponsorPhase 1Jun 28, 2019
Details
- Founded
- Laguna Hills, CA, US Jun 1, 2017
- Last known activity
- Sep 30, 2025